Fig. 2From: Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711a MIV-711 concentrations in monkey plasma at various time points after a single dose. b Plasma CTX-I levels measured in the same samples as in a. c Relationship between MIV-711 exposure (AUC0–24h) and % inhibition of plasma CTX-I over 24 h. Mean ± SEMBack to article page